期刊文献+

2%利多卡因凝胶鼻腔内涂抹治疗三叉神经痛 被引量:7

INTRANASAL LIDOCAINE-HYDROCHLORIDE-MUCILAGE 2% FOR TRIGEMINAL NEURALGIA
暂未订购
导出
摘要 目的:研究2%利多卡因凝胶鼻腔内涂抹治疗Ⅱ支三叉神经痛的疗效。方法:20例Ⅱ支三叉神经痛的患者随机分至两组,分别在患侧鼻腔涂抹2%利多卡因凝胶2ml或生理盐水对照。7天后两组患者交换。触碰面部诱发疼痛发作,测定给药前和给药后15分钟疼痛视觉模拟评分(VAS),并记录疼痛是否再次出现以及一次给药后疼痛有效控制的持续时间。结果:利多卡因组VAS值显著下降(P〈0.01),而生理盐水组无显著变化。治疗效果平均维持4.5小时(范围0.5-24小时)。结论:2%利多卡因凝胶鼻腔内涂抹治疗Ⅱ支三叉神经痛能迅速显效并维持一段时间,无严重不良反应。 paroxysmal Objective : To evaluate pain in second-division trigeminal neuralgia the effectiveness of intranasal lidocaine-hydrochloride-mucilage 2% on trigeminal neuralgia. Methods: Twenty patients with second-division were randomized to receive 2ml of either lidocaine-hydrochloride-mueilage 2% or saline placebo in the affected nostril. After a 7 day period, patients were crossed over to receive the alternative treatment. The paroxysmal pain triggered by touching was assessed with a 10 cm visual analogue scale (VAS) before and 15 min after treatment. Patients were asked to record whether the pain relieved and how long after therapy it recurred. Results: Intranasal lidocaine 2% significantly decreased VAS, whereas the placebo did not. The effect of treatment persisted for 4.5 h ( range 0.5 - 24 h). Conclusion : Intranasal lidocaine-hydrochloride-mucilage 2% produced prompt but temporary analgesia without serious adverse reactions in patients with second-division trigeminal neuralgia
出处 《中国疼痛医学杂志》 CAS CSCD 2009年第4期200-202,共3页 Chinese Journal of Pain Medicine
关键词 三叉神经痛 区域镇痛 利多卡因 Trigeminal neuralgia Local anesthetic techniques Lidocaine
  • 相关文献

参考文献13

  • 1de Castro AR, de Siqueira SR, Perissinotti DM,et al. Psychological evaluation and cope with trigeminal neuralgia and temporomandibular disorder. Arq Neuropsiquiatr, 2008,66:716-719.
  • 2Peterson JN, Schames J, Schames M, nopalatine ganglion block: a safe and et al. Spheeasy method for the management of orofacial pain. Cranio, 1995, 13 : 177- 181.
  • 3Kerr FW. Evidence for a peripheral etiology of trigeminal neuralgia. J Neurosurg, 2007, 107 : 225.
  • 4Cruccu G, Gronseth G, Alksne J, et al. AANEFNS guidelines on trigeminal neuralgia management. Eur J Neurol, 2008, 15 : 1013 - 1028.
  • 5Jorns TP, Zakrzewska JM. Evidence - based approach to the medical management of trigeminal neuralgia. Br J Neurosurg, 2007, 21 : 253.
  • 6Prasad S, Galetta S. Trigeminal neuralgia : historical notes and current concepts. Neurologist,2009,15 : 87 - 94.
  • 7Goadsby PJ, Duckworth JW. Effect of stimulation of trigeminal ganglion on regional cerebral blood flow in cats. Am J Physiol, 1987,253 : R270 - 274.
  • 8Nozaki K, Moskowitz MA, Maynard KI, et al. Possible origins and distribution of immunoreactive nitric oxide synthase -containing nerve fibers in cerebral arteries. J Cereb Blood Flow Metab, 1993,13 : 70 -79.
  • 9Love S, Coakham HB. Trigeminal neuralgia: pathology and pathogenesis. Brain,2001,124 : 2347 2360.
  • 10Backonja MM. Use of anticonvulsants for treatment of neuropathic pain. Neurology,2002, 59 : S1 4-7.

同被引文献46

引证文献7

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部